Publications 2017

January 2017

  1. Boudville N, Cho Y, Equinox KL, Figueiredo AE, Hawley CM, Howard K, Johnson DW, Jose M, Lee A, Maley M, Maley J, Pascoe EM, Steiner GZ, Tomlins M, Voss D, Chow J. Teaching peritoneal dialysis in Australia: An opportunity for improvement. Nephrology 2017.(DOI: 10.1111/nep.12992)

  2. Campbell DJ, Mudge DW, Gallagher MP, Lim WH, Dwarakanathan R, Saweirs W, Craig JC. Infection prophylaxis in peritoneal dialysis patients: Results from an Australia/New Zealand survey. Peritoneal Dialysis International 2017. (DOI: 10.3747/pdi.2016.00037)

  3. Kalil AC, Johnson DW, Lisco SJ, Sun J. Early goal-directed therapy for sepsis: A novel solution for discordant survival outcomes in clinical trials. Critical Care Medicine 2017. (DOI:   10.1097/ccm.0000000000002235)

  4. Kim S, Macaskill P, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig JC.  Beginning the trajectory to ESKD in adult life: Albuminuria in Australian aboriginal children and adolescents. Pediatric Nephrology 2017; 32(1), 119-129. (DOI: 10.1007/s00467-016-3429-y)

  5. Lim WH, Wong G, Pilmore HL, McDonald SP,  Chadban SJ. Long-term outcomes of kidney transplantation in people with type 2 diabetes: A population cohort study. Lancet Diabetes Endocrinology 2017; 5(1): 26-33. (DOI: 10.1016/s2213-8587(16)30317-5)

  6. Mahady SE, Gale J, Macaskill P, Craig JC,  George J. Prevalence of elevated alanine transaminase in Australia and its relationship to metabolic risk factors: A cross-sectional study of 9,447 people. Journal of Gastroenterology and  Hepatology 2017; 32(1): 169-170. (DOI: 10.1111/jgh.13434)

  7. Nataatmadja M, Cho Y, Johnson DW. Evidence for biocompatible peritoneal dialysis solutions. Contributions to Nephrology 2017; 189: 91-101. (DOI: 10.1159/000450690)

  8. Pinter J, Hanson CS, Chapman JR, Wong G, Craig JC, Schell JO, Tong A. Perspectives of older kidney transplant recipients on kidney transplantation. Clinical Journal of the American Society of Nephrology 2017. (DOI: 10.2215/cjn.05890616)

  9. Small DM, Beetham KS, Howden EJ, Briskey DR, Johnson DW, Isbel NM, Gobe GC, Coombes JS. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Reports 2017; 1-10. (DOI: 10.1080/13510002.2016.1276314

  10. Sumpton D, Thakkar V, O’Neill S, Singh-Grewal D, Craig JC, Tong A. “It’s not me, it’s not really me.” Insights from patients on living with systemic sclerosis: An interview study. Arthritis Care Research 2017. (DOI: 10.1002/acr.23207)

  11. Szeto CC, Johnson DW. Low GDP solution and glucose-sparing strategies for peritoneal dialysis. Seminars in Nephrology 2017; 37(1): 30-42. (DOI: 10.1016/j.semnephrol.2016.10.005)

  12. Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, Crowe S, Van Biesen W, Winkelmayer WC, O’Donoghue D, Tam-Tham H, Shen JI, Pinter J, Larkins N, Youssouf S, Mandayam S, Ju A, Craig JC. Establishing core outcome domains in hemodialysis: Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop. American Journal of Kidney Diseases 2017; 69(1): 97-107. (DOI: 10.1053/j.ajkd.2016.05.022)

  13. Tong A, Sautenet B, Chapman JR, Harper C, MacDonald SP, Shackel N, Crowe S, Hanson C, Hill S, Synnot A, Craig JC. Research priority setting in organ transplantation: A systematic review. Transplant International 2017; 30(4), 327-343. (DOI: 10.1111/tri.12924)

  14. Wong G, Hayward JS, McArthur E, Craig JC, Nash DM, Dixon SN, Zimmerman D, Kitchlu A, Garg AX. Patterns and predictors of screening for breast and cervical cancer in women with CKD. Clinical Journal of the American Society of Nephrology 2017; 12(1): 95-104. (DOI: 10.2215/cjn.05990616)

February 2017

  1. Briskey D, Tucker P, Johnson DW, Coombes JS. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clinical and Experimental Nephrology 2017; 21(1): 7-15.(DOI: 10.1007/s10157-016-1255-y)

  2. Chan S, Au K, Francis RS, Mudge DW, Johnson DW, Pillans PI. Phosphate binders in patients with chronic kidney disease. Australian Prescriber 2017; 40(1): 10-14. (DOI: 10.18773/austprescr.2017.002)

  3. Chan S, Cho Y, Koh YH, Boudville NC, Clayton PA, McDonald SP, Pascoe EM, Francis RS, Mudge DW, Borlace M, Badve SV, Sud K, Hawley CM, Johnson DW. Association of socio-economic position with technique failure and mortality in Australian non-indigenous peritoneal dialysis patients. Peritoneal Dialysis International 2017. (DOI: 10.3747/pdi.2016.00209)

  4. Chan S, Mallett AJ, Patel C, Francis RS, Johnson DW, Mudge DW, Isbel NM. Recurrent atypical haemolytic uraemic syndrome post kidney transplant due to a CD46 mutation in the setting of SMARCAL1-mediated inherited kidney disease. Nephrology 2017; 22 Suppl 1: 11-14. (DOI: 10.1111/nep.12933)

  5. Chapman JR. Progress in transplantation: Will it be achieved in big steps or by marginal gains? American Journal of Kidney Disease 2017; 69(2): 287-295. (DOI: 10.1053/j.ajkd.2016.08.024)

  6. Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Sautenet B, O’Donoghue D, Tam-Tham H, Youssouf S, Mandayam S, Ju A, Hawley C, Pollock C, Harris DC, Johnson DW, Rifkin DE, Tentori F, Agar J, Polkinghorne KR, Gallagher M, Kerr PG, McDonald SP, Howard K, Howell M, Craig JC. Developing a set of core outcomes for trials in hemodialysis: An international delphi survey. American Journal of Kidney Diseases 2017. (DOI: 10.1053/j.ajkd.2016.11.029)

  7. Fernando MR, Dent H, McDonald SP, Rangan GK. Incidence and survival of end-stage kidney disease due to polycystic kidney disease in australia and new zealand (1963-2014). Popul Health Metr 2017; 15(1): 7. (DOI: 10.1186/s12963-017-0123-7)

  8. Htay H, Johnson DW, Wu SY, Oei EL, Foo MW, Choo JC. Comparison of topical chlorhexidine and mupirocin for the prevention of exit-site infection in incident peritoneal dialysis patients. Peritoneal Dialysis International 2017. (DOI: 10.3747/pdi.2016.00257)

  9. Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR. Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial. JAMA Intern Med 2017; 177(2): 184-193. (DOI: 10.1001/jamainternmed.2016.8029)

  10. James LJ, Wong G, Craig JC, Ju A, Williams N, Lim WH, Cross N, Tong A. Beliefs and attitudes to bowel cancer screening in patients with CKD: A semistructured interview study. Clinical Journal of the American Society of Nephrology 2017; 12(4), 568-576. (DOI: 10.2215/cjn.10090916)

  11. Kelly JT, Rossi M, Johnson DW, Campbell KL. Beyond sodium, phosphate and potassium: Potential dietary interventions in kidney disease. Seminars in Dialysis 2017. (DOI: 10.1111/sdi.12580)

  12. Kim S, Lewis JR, Baur LA, Macaskill P, Craig JC. Obesity and hypertension in australian young people: Results from the Australian health survey 2011-2012. Intern Med J 2017; 47(2): 162-169. (DOI: 10.1111/imj.13298)

  13. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naicker S, Pecoits-Filho R, Yu XQ, Lameire N. Changes in the worldwide epidemiology of peritoneal dialysis. Nature Reviews in Nephrol 2017; 13(2): 90-103. (DOI: 10.1038/nrneph.2016.181)

  14. Palmer SC, Tunnicliffe DJ, Singh-Grewal D, Mavridis D, Tonelli M, Johnson DW, Craig JC, Tong A, Strippoli GF. Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: A network meta-analysis of randomized trials. American Jounral of Kidney Diseases 2017. (DOI: 10.1053/j.ajkd.2016.12.008)

  15. Saglimbene V, Palmer S, Scardapane M, Craig JC, Ruospo M, Natale P, Gargano L, Leal M, Bednarek-Skublewska A, Dulawa J, Ecder T, Stroumza P, Marco Murgo A, Schon S, Wollheim C, Hegbrant J, Strippoli GF. Depression and all-cause and cardiovascular mortality in patients on haemodialysis: A multinational cohort study. Nephrology Dialysis Transplantation 2017; 32(2): 377-384. (DOI: 10.1093/ndt/gfw016)

  16. Tong A, Winkelmayer WC, Wheeler DC, van Biesen W, Tugwell P, Manns B, Hemmelgarn B, Harris T, Crowe S, Ju A, O’Lone E, Evangelidis N, Craig JC. Nephrologists’ Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis.  Clinical Journal of the American Society of Nephrology 2017 (DOI: 10.2215/cjn.08370816)

  17. Wong G, Chakera A, Chapman JR, Chadban SC, Pilmore H, Craig JC, Lim WH. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system? Transplantation and Infectious Diseases 2017; 19(1). (DOI: 10.1111/tid.12631)

March 2017

  1. Campbell DJ, Mudge DW, Gallagher MP, Lim WH, Ranganathan D, Saweirs W, & Craig JC. Infection prophylaxis in peritoneal dialysis patients: Results from an Australia/New Zealand survey. Peritoneal Dialysis International 2017; 37(2), 191-197. (DOI: 10.3747/pdi.2016.00037)

  2. Francis A, Johnson DWCraig JC, & Wong G. Incidence and predictors of cancer following kidney transplantation in childhood. American Journal of  Transplantation 2017. (DOI: 10.1111/ajt.14289)

  3. Mahady SE, Macaskill P, Craig JC, Wong GL, Chu WC, Chan HL, George J, Wong VW. Diagnostic accuracy of non-invasive fibrosis scores in a population of individuals with a low prevalence of fibrosis. Clinical Gastroenterology and Hepatology 2017. (DOI: 10.1016/j.cgh.2017.02.031)

  4. Nankivell BJ, Renthawa J, Sharma RN, Kable K, O’Connell PJ, Chapman JR.  BK virus nephropathy: Histological evolution by sequential pathology. American Journal of Transplantation 2017. (DOI: 10.1111/ajt.14292)

  5. Pinter J, Hanson CS, Chapman JR, Wong G, Craig JC, Schell JO, Tong A. Perspectives of older kidney transplant recipients on kidney transplantation. Clinical Journal of the American Society of Nephrology. 2017; 12(3), 443-453. (DOI: 10.2215/cjn.05890616)

  6. Saglimbene V, Palmer SC, Craig JC, Ruospo M, Nicolucci A, Tonelli M, Johnson D, Lucisano G, Williams G, Valentini M, D’Alonzo D, Pellegrini F, Strippoli P, Salomone M, Santoro A, Maffei S, Hegbrant J, Tognoni G, Strippoli GF and CE-DOSE Study Investigators. Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial. PLoS One. 2017 Mar 1;12(3):e0172735. (DOI: 10.1371/journal.pone.0172735)

  7. Small DM, Beetham KS, Howden EJ, Briskey DR, Johnson DW, Isbel NM, Gobe GC, Coombes JS. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report. 2017; 22(3): 127-136. (DOI: 10.1080/13510002.2016.1276314)

  8. Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, Ito Y, Kazancioglu R, Moraes T, Van Esch S, Brown EA. ISPD catheter-related infection recommendations: 2017 update. Peritoneal Dialysis International 2017; 37(2): 141-154. (DOI: 10.3747/pdi.2016.00120)

  9. Tong A, Winkelmayer WC, Wheeler DC, van Biesen W, Tugwell P, Manns B, Hemmelgarn B, Harris T, Crowe S, Ju A, O’Lone E, Evangelidis N, Craig JC.  Nephrologists’ perspectives on defining and applying patient-centered outcomes in hemodialysis. PLoS One 2017; 12(3): 454-466. (DOI: 10.1371/journal.pone.0172735 10.2215/cjn.08370816)

  10. Tunnicliffe DJ, Singh-Grewal D, Craig JC, Howell M, Tugwell P, Mackie F, Lin MW, O’Neill SG, Ralph AF, Tong A. Healthcare and research priorities of adolescents and young adults with systemic lupus erythematosus: A mixed-methods study. Journal of Rheumatology 2017  (DOI: 10.3899/jrheum.160720

  11. Wong G, Craig JC, Chapman JR. Setting the limit for living kidney donation-how big is too big? Kidney International 2017; 91(3): 534-536. (DOI: 10.2215/cjn.08370816 10.1016/j.kint.2016.11.027

  12. Young C, Tong A, Gunasekera H, Sherriff S, Kalucy D, Fernando P, Craig JC.  Health professional and community perspectives on reducing barriers to accessing specialist health care in metropolitan Aboriginal communities: A semi-structured interview study. Journal of Paediatrics and Child Health. 2017; 53(3):277-282. (DOI: 10.1111/jpc.13374).

April 2017

  1. Campbell D, Mudge DW, Craig JC, Johnson DW, Tong A, Strippoli GF. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database of Systematic Reviews2017; 4, Cd004679 (DOI: 10.1002/14651858.CD004679.pub32017)

  2. Chong LSH, Sautenet B, Tong A, Hanson CS, Samuel S, Zappitelli M, Dart A, Furth S, Eddy AA, Groothoff J, Webb NJA, Yap HK, Bockenhauer D, Sinha A, Alexander SI, Goldstein SL, Gipson DS, Raman G, Craig JC. Range and heterogeneity of outcomes in randomized trials of pediatric chronic kidney disease. Journal of Pediatrics. 2017 (DOI: 10.1016/j.jpeds.2017.03.034)

  3. Joseph PD, Caldwell PH, Barnes EH, Craig JC. Disease burden-research match? Registered trials in child health from low- and middle-income and high-income countries. Journal of Paediatrics and Child Health. 2017 (DOI: 10.1111/jpc.13537)

  4. Kable K, Davies CD, O’Connell PJ, Chapman JR, Nankivell BJ. Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin. Transplantion Direct. 2017; 3(4), e142. (DOI: 10.1097/txd.0000000000000641)

  5. Nataatmadja M, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW. Association between peritoneal glucose exposure and peritonitis in peritoneal dialysis patients: The BALanz trial. Peritoneal Dialysis International. 2017.(DOI: 10.3747/pdi.2016.00263)

  6. Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GF. Dietary interventions for adults with chronic kidney disease. Cochrane Database of Systematic Reviews 2017; 4, Cd011998. (DOI: 10.1002/14651858.CD011998.pub2)

  7. Ritchie AG, Clayton PA, McDonald SP, Kennedy SE. Age-specific risk of renal graft loss from late acute rejection or noncompliance in the adolescent and young adult period. Nephrology 2017.(DOI: 10.1111/nep.13067)

  8. Rossignol P, Agarwal R, Canaud B, Charney A, Chatellier G, Craig JC, Cushman WC, Gansevoort RT, Fellstrom B, Garza D, Guzman N, Holtkamp FA, London GM, Massy ZA, Mebazaa A, Mol PGM, Pfeffer MA, Rosenberg Y, Ruilope LM, Seltzer J, Shah AM, Shah S, Singh B, Stefansson BV, Stockbridge N, Stough WG, Thygesen K, Walsh M, Wanner C, Warnock DG, Wilcox CS, Wittes J, Pitt B, Thompson A, Zannad F. Cardiovascular outcome trials in patients with chronic kidney disease: Challenges associated with selection of patients and endpoints. European Heart Journal. 2017 (DOI: 10.1093/eurheartj/ehx209)

May 2017

  1. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako BL, Rateb A, Osman MA, Qarni B, Saad S, Lunney M, Wiebe N, Ye F, Johnson DW. Assessment of Global Kidney Health Care Status. JAMA  2017;317(18):1864-81. (DOI 10.1186/s12882-017-0574-x)

  2. Campbell KL, Palmer SC, Johnson DW. Improving Nutrition Research in Nephrology: An Appetite for Change. American Journal of Kidney Diseases. 2017;69(5):558-60.(DOI 10.1053/j.ajkd.2017.02.006.)

  3. Manera KE, Hanson CS, Chapman JR, Kanellis J, Gill J, Craig JC, Chadban SJ, Wong G, Ralph AF, Tong A. Expectations and Experiences of Follow-up and Self-Care After Living Kidney Donation: A Focus Group Study. Transplantation. 2017;101(10):2627-35.(DOI: 10.1097/TP.0000000000001771.)

  4. Reith C, Staplin N, Herrington WG, Stevens W, Emberson J, Haynes R, Mafham M, Armitage J, Cass A, Craig JC, Jiang L, Pedersen T, Baigent C, Landray MJ, SHARP Collaborative Group. Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection. BMC nephrology. 2017;18(1):147.(DOI: 10.1186/s12882-017-0545-2.)

  5. Ruospo M, Palmer SC, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Del Castillo D, Schon S, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Bots CP, Strippoli GF. Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study. BMC nephrology. 2017;18(1):166.(DOI: 10.1186/s12882-017-0574-x).

  6. 6. Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi L-S, Ong L-M, Irish AB, FAVOURED study team. Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. Nephrology. 2017;22(10):823-4. (DOI: 10.1111/nep.12823.)

June 2017

  1. Cho Y, Htay H, Johnson DW. Centre effects and peritoneal dialysis-related peritonitis. Nephrol Dial Transplant 2017; 32(6):913-915 (DOI 10.1093/ndt/gfx054)

July 2017

  1. Chan S, Cho Y, Koh YH, Boudville NC, Clayton PA, McDonald SP, Pascoe EM, Francis RS, Mudge DW, Borlace M,

    Badve SV, Sud K, Hawley CM, Johnson DW. Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients. Peritoneal Dialysis International. 2017;37(4):397-406. (DOI 10.3747/pdi.2016.00209)

  2. Francis A, Johnson DW, Craig JC, Wong G. Moving on: transitioning young people with chronic kidney disease to adult care. Pediatric Nephrology. 2017.(DOI: 10.1007/s00467-017-3728-y.)

  3. Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P, HERO Study Collaborative Group. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Nephrology  2017;22(7):548-54.(DOI: 10.1111/nep.12815.)

  4. Hoy WE, Mott SA, McDonald SP. Follow-up reply to Dr Paul Lawton’s “A response to an expanded nationwide view of chronic kidney disease in Aboriginal Australians, Nephrology, 21 (2016), 916-922”. Nephrology. 2017;22(7):574.(DOI: 10.1111/nep.13041.)

  5. Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW. Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis. Clinical Journal of the American Society of Nephrology. 2017;12(7):1090-9.(DOI: 10.2215/CJN.12321216)

  6. Webster AC, Wu S, Tallapragada K, Park MY, Chapman JR, Carr SJ. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. The Cochrane database of systematic reviews. 2017;7:Cd004756.(DOI: 10.1002/14651858.CD004756.pub4

August 2017

  1. Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, Teixeira-Pinto A, Wong G. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017;92(2):461-9. (DOI 10.1016/j.kint.2017.03.015).

  2. Lawton PD, McDonald SP, Snelling PL, Hughes J, Cass A. Organ Transplantation in Australia: Inequities in Access and Outcome for Indigenous Australians. Transplantation. 2017. (DOI: 10.1097/TP.0000000000001911.)

  3. Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu Z-H, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang H-Y, Perkovic V, TESTING Study Group. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. JAMA. 2017;318(5):432-42.(DOI: 10.1001/jama.2017.9362.)

  4. Mohammadi FA, Borg M, Gulyani A, McDonald SP, Jesudason S. Pregnancy outcomes and impact of pregnancy on graft function in women after kidney transplantation. Clin Transplant. 2017.(DOI: 10.1111/ctr.13089.)

  5. Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J,Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O’Donoghue D,Tam-Tham H, Halimi J-M, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T, Craig JC. Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. Transplantation. 2017;101(8):1875-86.(DOI: 10.1097/TP.0000000000001776.)

  6. Manera KE, Tong A, Craig JC, Brown EA, Brunier G, Dong J, Dunning, T, Mehrotra R, Naicker S, Pecoits-Filho R, Perl J. Standardized outcomes in nephrology-peritoneal dialysis (SONG-PD): Study protocol for establishing a core outcome set in PD. Peritoneal Dialysis.2017 (DOI : 10.3747/pdi.2017.00022 ).

 September 2017

  1. Chapman JR. Seeking to close the loopholes in transplant tourism and organ trafficking. Transplantation. 2017 (DOI 10.1097/tp.0000000000001955)

  2. Howell M, Yeo R, Tong A, Craig JC, Howard K, Wong G. Completeness of reporting of adverse events in trials of maintenance immunosuppression in kidney transplantation: a systematic review. Nephrology, Dialysis, Transplantation. 2017;32(9):1586-94. (DOI 10.1093/ndt/gfx216)

  3. ohnson DW, Cleland B, Eris J, Rafferty T, Sud K, Chow JS. Administration of erythropoiesis-stimulating agents in patients undergoing haemodialysis: a time and motion study. Journal of Renal Care. 2017.(DOI 10.1111/jorc.12213)

  4. Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, Mudge DW, Campbell S, Elder GJ, Toussaint ND, Isbel NM. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD. BMC nephrology. 2017;18(1):281. (DOI 10.1186/s12882-017-0705-4)

  5. Larkins N, Teixeira-Pinto A, Banks E, Gunasekera H, Cass A, Kearnes J, Craig JC. Blood pressure among Australian Aboriginal children. Blood Pressure. 2017;35(9):1801-7. (DOI 10.1080/08037051.2017.1380502 10.1097/hjh.0000000000001401)

  6. Larkins NG, Teixeira-Pinto A, Craig JC. The prevalence and predictors of hypertension in a National Survey of Australian Children. Blood pressure. 2017(22):1-7 (DOI 10.1080/08037051.2017.1380502)

  7. See EJ, Johnson DW, Hawley CM, Pascoe EM, Darssan D, Clayton PA, Borlace M, Badve SV, Sud K, Boudville NC, Cho Y. Early peritonitis and its’ outcome in incident peritoneal dialysis patinets. Peritoneal Dialysis International.  2017 (DOI10.3747/pdi.2017.00029)

  8. Shen K, Johnson DW, Vesey DA, McGuckin MA, Gobe GC. Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies. Journal of Renal Care. 2017. (DOI 10.1111/jorc.12213 10.1007/s12192-017-0844-3)

  9. Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, Liu X, McTaggart S, Morrish AT, Playford G, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW. Representativeness of Honeypot Trial Participants to Australasian PD Patients. Peritoneal Dialysis International. 2017;37(5):516-22. (DOI 10.1053/j.ajkd.2016.12.008 10.3747/pdi.2016.00065)


Sign up for our Newsletter

Join Now
I am a

Back to Top